Impaired glucose metabolism has been shown to cause metabolic, neural, and circulatory disturbances.
Two phase 3 clinical trials examined mepolizumab 100 or 300 mg vs placebo to treat moderate-to-severe COPD exacerbations.
Participants received web-based OSA education, CPAP telemonitoring with automated feedback, both, or usual care.
Oral corticosteroids did not reduce symptom severity or duration in patients with lower respiratory tract infections without asthma.
Researchers hypothosized that increased sputum Gammaproteobacteria:Firmicutes ratio may serve as a biomarker to guide antibiotic treatment in COPD.
Self-prescribed apricot kernel extract was administered daily for 5 years by the patient.
Canakinumab vs placebo showed promising results in preventing recurrent cardiovascular events and incidences of lung cancer.
Advanced emphysema may benefit from endoscopic lung reduction treatment.
Asking patients to stop smoking before undergoing cosmetic surgery can promote long-term smoking cessation with 40.5% of participants in a recent study no longer smoking on a daily basis.
Gastroesophageal reflux disease (GERD) is associated with long-term risk of pneumonia, especially in the younger population and in patients who have been treated with proton pump inhibitors.
People with COPD have been found to benefit from statin therapies, with reduced risk of all-cause and pulmonary-related mortality.
Patients with COPD treated with mucolytic agents for at least 1 year were better protected against exacerbations compared with patients treated with placebo.
Data from 5 phase 2/3 studies demonstrate improved weight and body mass in patients with NSCLC receiving anamorelin.
The correlation between patient race and ethnicity and administration of antibiotic treatment for viral acute respiratory tract infections was examined.
Adults with asthma benefit from tailoring interventions based on sputum eosinophils vs clinical symptoms.
Researchers analyzed over 2.1 million patient-years’ worth of data to determine the impact of short-acting beta agonist use in asthma.
The American Academy of Pediatrics recommends against the use of the quadrivalent live attenuated influenza vaccine (LAIV4).
Participants received 70 mg of tezepelumab every 4 weeks throughout the study.
Questions involving physician-diagnosed COPD have a low sensitivity and a high specificity.
A phase 3 trial examined the efficacy of chemoimunnotherapy vs chemotherapy alone in postsurgical patients with non-small cell lung cancer.
Three cases of community-acquired pneumonia were reported in otherwise healthy adults.
FEV1 was higher in patients who received tiotropium therapy vs those in the placebo group.
Patients identified as having high-risk obstructive sleep apnea by the STOP-Bang Questionnaire were more likely to have postoperative complications and longer hospital stays.
A retrospective study of lung cancer clinical trials found that trials continue to increase their eligibility criteria, creating barriers to patient access.
Priority review for alectinib was granted based on evidence from the phase 3 ALEX and J-ALEX clinical trials.
A computer-based alert system does not increase thromboprophylaxis among patients in general medical wards at hospitals.
Patients with chronic obstructive pulmonary disease, particularly with exacerbations, have an increased risk for diabetes development.
Durvalumab can be used to treat patients with locally advanced, unrescetable NSCLC, who do not relapse after platinum-based chemoradiation.
Respiratory infection frequency during the first 2 years of life is tied to celiac disease risk in high-risk children.
Study results suggest that smoking status is a potential independent risk factor for psoriasis.